Viking Therapeutics, Inc. (VKTX) Current Ratio % [USD] 2015 - 2024

Historical data

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Viking Therapeutics, Inc. quarterly Current Ratio history and growth rate from 2015 to 2024.
  • Viking Therapeutics, Inc. Current Ratio for the quarter ending March 31, 2024 was 2.68 K %, a 170% increase year-over-year.
Current Ratio, Quarterly (% [USD])
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q1 2024 2.68 K +1.69 K +170% Mar 31, 2024
Q4 2023 2.1 K +969 +85.3% Dec 31, 2023
Q3 2023 1.7 K +172 +11.3% Sep 30, 2023
Q2 2023 1.35 K -394 -22.6% Jun 30, 2023
Q1 2023 994 -961 -49.2% Mar 31, 2023
Q4 2022 1.14 K -874 -43.5% Dec 31, 2022
Q3 2022 1.53 K -435 -22.2% Sep 30, 2022
Q2 2022 1.75 K -367 -17.4% Jun 30, 2022
Q1 2022 1.96 K -417 -17.6% Mar 31, 2022
Q4 2021 2.01 K -695 -25.7% Dec 31, 2021
Q3 2021 1.96 K -1.24 K -38.8% Sep 30, 2021
Q2 2021 2.11 K -1.55 K -42.3% Jun 30, 2021
Q1 2021 2.37 K -1.84 K -43.7% Mar 31, 2021
Q4 2020 2.7 K -2.25 K -45.5% Dec 31, 2020
Q3 2020 3.21 K -2.35 K -42.3% Sep 30, 2020
Q2 2020 3.66 K -2.39 K -39.5% Jun 30, 2020
Q1 2020 4.21 K -1.53 K -26.7% Mar 31, 2020
Q4 2019 4.96 K +743 +17.6% Dec 31, 2019
Q3 2019 5.56 K +3.25 K +141% Sep 30, 2019
Q2 2019 6.06 K +5.16 K +578% Jun 30, 2019
Q1 2019 5.74 K +5.35 K +1370% Mar 31, 2019
Q4 2018 4.21 K +4 K +1887% Dec 31, 2018
Q3 2018 2.31 K +2.11 K +1056% Sep 30, 2018
Q2 2018 893 +645 +261% Jun 30, 2018
Q1 2018 391 +102 +35.4% Mar 31, 2018
Q4 2017 212 -85.1 -28.6% Dec 31, 2017
Q3 2017 200 -190 -48.7% Sep 30, 2017
Q2 2017 247 -173 -41.2% Jun 30, 2017
Q1 2017 289 -184 -39% Mar 31, 2017
Q4 2016 297 +156 +111% Dec 31, 2016
Q3 2016 390 +321 +461% Sep 30, 2016
Q2 2016 421 Jun 30, 2016
Q1 2016 473 Mar 31, 2016
Q4 2015 141 Dec 31, 2015
Q3 2015 69.6 Sep 30, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.